EurekAlert! -
14 Oct 2020 06:00
(University of California - San Diego) Treatment with a peptide that mimics the naturally occurring protein GIV prevents immune overreaction and supports a mechanism critical for survival in mouse models of sepsis and colitis, according to a UC San Diego study.
Share this Article